Interestingly, CMML patients exhibit higher background concentrations of the above-mentioned pro-inflammatory cytokines, and these same pro-inflammatory mediators (IL-1β, IL-6, TNFα) have been reported to promote AML aggressiveness [15]. Here, IL6 is linked to acute myeloid leukemia.